# The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery

Study · id `cardio:ct-nct06798714` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06798714](<https://clinicaltrials.gov/study/NCT06798714>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06798714

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

## Technical summary

Registry record NCT06798714. Randomized; triple masking; primary purpose prevention. Start 2025-01-20 (actual); primary completion 2025-07-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 140 participants (enrolled count; ClinicalTrials.gov record NCT06798714, source copy `cardio:ctgov-nct06798714-2026-09-30`, retrieved 2026-10-26)
- Started: 2025-01-20 (actual) (ClinicalTrials.gov record NCT06798714, source copy `cardio:ctgov-nct06798714-2026-09-30`, retrieved 2026-10-26)
- Primary completion: 2025-07-20 (actual) (ClinicalTrials.gov record NCT06798714, source copy `cardio:ctgov-nct06798714-2026-09-30`, retrieved 2026-10-26)
- Completion: 2026-02-20 (actual) (ClinicalTrials.gov record NCT06798714, source copy `cardio:ctgov-nct06798714-2026-09-30`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT06798714, source copy `cardio:ctgov-nct06798714-2026-09-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06798714-2026-09-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
- Acronym: CAFE
- Condition: Coronary Artery Disease
- Condition: Atrial Fibrillation
- Condition: Coronary Artery Bypass Grafting
- Condition: Colchicine
- Intervention (Drug): NSAID
- Intervention (Drug): Colchicine 0.5 MG
- Lead sponsor: Tomsk Cardiology Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 408dcb2869dbb3b6cbba74d484b739403216a04e499bc49b10bc598280e26444
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
